Patients with EM or CTD-related CryoVas often experience relapse following RTX and corticosteroid-induced remission.

Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries.

A research team led by Virginia Commonwealth University has gained new insights into the molecular mechanisms that cause ...